The radiotherapy segment is expected to witness significant market growth over the forecast period owing to factors such as the rising prevalence of cancer and the rising adoption of spacers during radiotherapy in treating various cancer types. North America Dominates the Absorbable Tissue Spacer Market and Expects to do the Same Over the Forecast Period. NEWARK, DE / ACCESSWIRE / December 9, 2024 / The global absorbable tissue spacer market is on a strong growth trajectory, with projections forecasting a significant surge to surpass USD 303.8 million by 2032. This growth is driven by a robust Compound Annual Growth Rate (CAGR) of approximately 10% during the forecast period from 2022 to 2032.A key factor contributing to this growth is the rising prevalence of prostate cancer, particularly among the aging male population. Prostate cancer is the second most common cancer in men in the United States, following skin cancer, according to the American Cancer Society. In 2019 alone, approximately 174,650 new cases of prostate cancer were reported, with an estimated 31,620 deaths attributed to the disease. The escalating incidence of prostate cancer highlights the urgent need for effective treatment solutions, such as absorbable tissue spacers, which help reduce complications and improve the outcomes of radiation therapy.Gain Valuable Market Knowledge: Request a Sample Report! https://www.fmisamplereport.com/sample/rep-gb-8507North America and Europe are expected to dominate the absorbable tissue spacer market, collectively accounting for three-quarters of the market share by 2032. North America, in particular, is poised to benefit from the presence of leading market players and a growing patient population. According to the National Cancer Institute, approximately 11.6% of men in the U.S. are expected to be diagnosed with prostate cancer during their lifetimes, further driving the demand for advanced treatment options like absorbable tissue spacers.Among the product types, hydrogel-based spacers are anticipated to lead the market, experiencing significant revenue growth. These spacers offer superior efficacy, durability, and a reduction in complications compared to conventional methods for maintaining rectal space during radiation therapy. The widespread adoption of hydrogel-based spacers can be attributed to their ability to improve patient outcomes and enhance the overall treatment experience.As the demand for absorbable tissue spacers continues to rise, key market players are actively investing in research and development, forging strategic partnerships, and innovating to meet the growing needs of the healthcare sector. These efforts are expected to accelerate market expansion and drive continued growth in the coming years. Key Takeaways: Absorbable Tissue Spacer MarketMarket size is expected to grow significantly, reaching over USD 303.8 million by 2032 from USD 80 million in 2018.Anticipated growth rate of around 10% annually between 2022 and 2032.Rising prostate cancer cases, particularly among older men, is a major driver. Prostate cancer is the second most common cancer in men after skin cancer (according to the American Cancer Society).North America and Europe are expected to hold the dominant share (three-fourths) of the market by 2032.North America's strong market presence and increasing prostate cancer rates are key factors for its growth. Over 11% of men in the US are likely to be diagnosed with prostate cancer in their lifetime (National Cancer Institute data).Hydrogel-based spacers are expected to be the most popular product type due to their widespread use and effectiveness.The market is predicted to experience strong growth due to the advantages of hydrogel spacers, such as improved efficiency, durability, and fewer complications compared to traditional methods for maintaining rectal space during treatment."The absorbable tissue spacer market is entering a phase of unprecedented growth driven by the escalating prevalence of prostate cancer and the increasing adoption of hydrogel-based solutions, as leaders in this space, we are committed to advancing innovative solutions that enhance patient outcomes and address the evolving needs of healthcare providers." said opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).Key Players:Boston Scientific Corporation (Augmenix)Palette Life SciencesBIOPROTECT LTD.BiocompositesKey SegmentHydrogel-Based SpacerBiodegradable Hyaluronic Acid SpacerBiodegradable Balloon SpacerCrystal-Based SpacerBy Product TypeBy ApplicationRadiotherapyInfection ManagementBy End UseHospitalsAmbulatory Surgical CentresSpecialized ClinicsBy RegionNorth AmericaLatin AmericaEuropeSouth AsiaEast AsiaOceaniaMEAExplore the Latest Trends and Opportunities in the Non-Vascular Stents Market - Stay Ahead with In-Depth Insights!Author By:Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.Explore FMI's related ongoing Coverage on Healthcare Market Insights Domain:The global sales of pharma grade synthetic camphor are estimated to be worth USD 449.3 million in 2024 and anticipated to reach a value of USD 652.4 million by 2034. Sales are projected to rise at a CAGR of 3.8% over the forecast period between 2024 and 2034.The ovulation test kit market size is estimated to reach USD 226.7 million in 2024. It is estimated that revenue will increase at a CAGR of 6.6% between 2024 and 2034. The market is anticipated to reach USD 429.5 million by 2034.The global skin tears treatment market share is estimated to be worth USD 478.0 million in 2024 and anticipated to reach a value of USD 674.3 million by 2034. Sales are projected to grow at a CAGR of 3.5% over the forecast period between 2024 and 2034.The disposable medical sensors market demand is estimated to reach USD 8.0 billion in 2024. It is estimated that revenue will increase at a CAGR of 8.1% between 2024 and 2034. The industry is anticipated to reach USD 17.9 billion by 2034.The global veterinary immunomodulators market growth are estimated to be worth USD 1,174.2 million in 2024 and are anticipated to reach a value of USD 2,023.6 million by 2034. Sales are projected to rise at a CAGR of 5.6% over the forecast period between 2024 and 2034.The narcolepsy treatment market trends is estimated to reach USD 5,301.6 million in 2024. It is estimated that revenue will increase at a CAGR of 5.1% between 2024 and 2034. The market is anticipated to reach USD 8,718.3 million by 2034.The women health applications market development is estimated to reach USD 4,515.9 million in 2024. It is estimated that revenue will increase at a CAGR of 14.6% between 2024 and 2034. The market is anticipated to reach USD 17,643.7 million by 2034.The chronic pain market strategies is estimated to reach USD 50,611.1 million in 2024. It is estimated that revenue will increase at a CAGR of 4.0% between 2024 and 2034. The market is anticipated to reach USD 74,757.4 million by 2034.The global ambulatory polysomnography (PSG) systems market outlook is estimated to be worth USD 309.45 million in 2024 and anticipated to reach a value of USD 516.47 million by 2034. Sales are projected to rise at a CAGR of 5.3% over the forecast period between 2024 and 2034.The MRI guided neurosurgical ablation market overview is estimated to reach USD 168.13 million in 2024. It is estimated that revenue will increase at a CAGR of 3.1% between 2024 and 2034. The market is anticipated to reach USD 227.56 million by 2034.About Future Market Insights (FMI)Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.Contact Us:Future Market Insights Inc.Christiana Corporate, 200 Continental Drive,Suite 401, Newark, Delaware - 19713, USAT: +1-347-918-3531For Sales Enquiries: [email protected]Website: https://www.futuremarketinsights.comLinkedIn | Twitter | Blogs | YouTubeSOURCE: Future Market Insights Inc.
